Angiogenix's Unattributed VC Round

Angiogenix raised a round of funding on July 21, 2003.

Angiogenix, Inc. is an early-stage biotechnology company developing products for peripheral and cardiac ischemia. The Company's ACCLAIM(tm product candidates are proprietary nitrates focused on replac…

Articles about Angiogenix's Unattributed VC Round: